Epidural and Intrathecal Analgesia Is Effective in Treating Refractory Cancer Pain
Allen W. Burton(Abbott (United States)), James F. Arens, Tito R. Mendoza(The University of Texas MD Anderson Cancer Center), Samuel J. Hassenbusch(The University of Texas MD Anderson Cancer Center), Charles S. Cleeland(The University of Texas MD Anderson Cancer Center), Hemant N. Shah, Arun Rajagopal
Cited by 141
Related Papers
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Practice Advisory for Preanesthesia Evaluation
|Anesthesiology|2012|840